Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2025-12-25 @ 2:34 AM
NCT ID: NCT03514134
Eligibility Criteria: Inclusion Criteria: 1. 16-26 years old and enrolled in high school or post-high school transition programming; 2. Educational Diagnosis of autism spectrum disorder using the Social Responsivity Scale 2nd Edition28, or a diagnosis of cognitive impairment, emotional disability, educational impairment or other health impairment according to the students Individualized Education Plan (IEP). They may have diagnosis of autism spectrum disorder as indicated in their IEP/school plan, or as indicated by a parent; 3. Fluency in English with at least a 3rd grade reading level (confirmed with the Wide Range Achievement Test); 4. Currently receiving transitional services as specified in IEP or other; 5. Willing to be video-recorded; and 6. Willing and able to provide informed consent. Exclusion Criteria: 1. Has an uncorrected hearing or visual problem that prevents him or her from using the training. 2. Has a medical illness that compromises their cognition (for example, moderate to severe traumatic brain injury) Inclusion and exclusion criteria is subject to PI discretion. Some students may still be enrolled after discussion with the teacher if it is determined that they still might be able to participate despite matching exclusion criteria, or not meeting all of the inclusion criteria. These cases will be documented and reported to IRB.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 16 Years
Maximum Age: 21 Years
Study: NCT03514134
Study Brief:
Protocol Section: NCT03514134